Serum Sphingosine‐1‐Phosphate Is Decreased in Patients With Acute‐on‐Chronic Liver Failure and Predicts Early Mortality-Reference-Cited by-同舟云学术

Serum Sphingosine‐1‐Phosphate Is Decreased in Patients With Acute‐on‐Chronic Liver Failure and Predicts Early Mortality

Published:2020-08-12 Issue:10 Volume:4 Page:1477-1486
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol. Commun.

Author:

Mücke Victoria T.¹^ORCID,Maria Schwarzkopf Katharina¹^ORCID,Thomas Dominique²,Mücke Marcus M.¹,Rüschenbaum Sabrina³,Trebicka Jonel¹^ORCID,Pfeilschifter Josef⁴,Zeuzem Stefan¹,Lange Christian M.³,Grammatikos Georgios¹⁵

Affiliation:

1. Departement of Internal Medicine 1 University Hospital FrankfurtGoethe University Frankfurt am Main Germany

2. Pharmazentrum Frankfurt Institute of Clinical Pharmacology Goethe University Frankfurt am Main Germany

3. Department of Gastroenterology and Hepatology University Hospital EssenUniversity of Duisburg‐Essen Essen Germany

4. Pharmazentrum Frankfurt Institute of General Pharmacology and Toxicology Goethe University Frankfurt am Main Germany

5. St. Luke’s Hospital Thessaloniki Panorama Greece

Funder

German Research Foundation Collaborative Research Centers

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1561

Reference47 articles.

1. Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

2. Acute-on-chronic liver failure: an update

3. Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis

4. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality

5. Sphingolipid metabolites in inflammatory disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury;Frontiers in Medicine;2023-09-08

2. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod;Journal of Hepatology;2023-07

3. Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure;American Journal of Physiology-Cell Physiology;2023-07-01

4. Progress on clinical prognosis assessment in liver failure;Liver Research;2023-06

5. Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids;Frontiers in Immunology;2022-03-31